Finance entity

Akshay Naheta

Person

Every one of those 2 sits in a single category, earnings. Of the tracked stories, 1 of 2 also mention Bakkt, the most common co-covered peer. That works out to roughly 0.1 stories per week across a 153-day span. The 5.5 average consequence score is below the beat benchmark of 6.2 in the same window.

Last mentioned: Aug 17, 2026

Entity pulse

Recent coverage · Akshay Naheta

↑
2 stories
5.5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Akshay Naheta

Every one of those 2 sits in a single category, earnings. Of the tracked stories, 1 of 2 also mention Bakkt, the most common co-covered peer. That works out to roughly 0.1 stories per week across a 153-day span. The 5.5 average consequence score is below the beat benchmark of 6.2 in the same window. Each story carries 3 original sources on average, compared with 2.9 for the broader beat in this window. This profile follows 2 Finance stories mentioning Akshay Naheta across the period from March 18, 2026 to August 17, 2026.

Stories tracked
2
Per week
0.1
Sources per story
3

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 2105 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Akshay Naheta. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Akshay Naheta 2

Earnings Neutral

Viant Q2 Revenue Up 34% to $104.3M, Guides $109M Midpoint

Viant delivered Q2 2026 revenue of $104.3M (up 34% YoY), non-GAAP EPS of $0.15, and raised Q3 revenue guidance to $107.5M–$110.5M. With $193.1M in cash, zero debt, and 24% adjusted EBITDA margin, the company is compounding profitability.

3 sources
Earnings Neutral

Tech and Biotech Pivot: LivePerson, Inovio, and Bakkt Realign for 2026 Growth

LivePerson, Inovio, and Bakkt reported Q4 2025 results highlighting strategic transitions toward AI integration, regulatory milestones, and balance sheet restructuring. While LivePerson capitalizes on generative AI adoption and Inovio nears a critical FDA PDUFA date, Bakkt has streamlined its capital structure to focus on institutional crypto services.

3 sources

Akshay Naheta is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.